Gornitzky represents the underwriters, led by Cantor Fitzgerald, in Kamada's follow-on offering.
Gornitzky represented the underwriters, led by Cantor Fitzgerald, in the USD 15 million follow-on offering of Kamada Ltd. on the NASDAQ Global Select Market. Kamada is a plasma-derived protein therapeutics company focused on orphan indications, and its shares are dually traded on the NASDAQ and the Tel Aviv Stock Exchange.
Cantor Fitzgerald acted as sole book-running manager for the offering. Raymond James, Oppenheimer & Co., Ladenburg Thalmann and Chardan acted as co-managers for the offering.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Yoav Meer (Associate), Danielle Skald (Associate) and Sharon Strauss (Associate).